{"ticker": {"uuid": "ecf778e0-d8d5-4981-9874-3c9123d8ff80", "symbol": "FYB", "name": "Formycon AG", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Formycon AG and OneSource Specialty Pharma Announce Strategic Manufacturing Partnership for Biosimilars", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUWtWY01uYlpzM3JVcHpsamVhZUhrQ3RiY3dhRTNrZTZkV3YtcE5mS0ozODFYVUxSWlBLNTlRcWdYMmJRWjJkVGx6NWJmZktSa0U2M3N1bmo2NjdUcUctWDJMRDdIYTVlajRHT2h1NXRyNnBlODd3dzRyUVNOTVNjSDhnUDdqcEptMHRTU3A1c1BOcWstbHo5YWNSTWJZZHFh?oc=5", "source_name": "Market source", "published_at": "2026-07-14T20:38:34+00:00", "published_display": "14 Jul 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource bags biosimilar manufacturing contract from Formycon", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQdHRDdWUydkpfT0pwZEpNUHliUE1odWtJOXF3TjQ5cFdlTlJPTTNRTUtLSnFfY05fcHhJSWZTZmU2a3h6OTJaeUE5aTZ4TXQzckM3cmNBdGFjNlgzTVZMYkktZjd1aFNxOEtPYlA4X2R2SlhaZ25UWHRwdHdZb20xX3VxZVVXaEJpRWZFNUR0bVZISFBERXlfWkhUeEJvQkRoOGxqVW9UV1JiWURHX2ZYVmdDbWRocmYxaEJla2VLY1ZhWHdQYzI0UGpKeGlvMGdsMWV2R2ZKM1PSAdgBQVVfeXFMUHR0Q3VlMnZKX09KcGRKTVB5YlBNaHVrSTlxd040OXBXZU5ST00zUU1LS0pxX2NOX3B4SUlmU2ZlNmt4ejkyWnlBOWk2eE10M3JDN3JjQXRhYzZYM01WTGJJLWY3dWhTcThLT2JQOF9kdkpYWmduVFh0cHR3WW9tMV91cWVVV2hCaUVmRTVEdG1WSEhQREV5X1pIVHhCb0JEaDhsalVvVFdSYllER19mWFZnQ21kaHJmMWhCZWtlS2NWYVh3UGMyNFBqSnhpbzBnbDFldkdmSjNT?oc=5", "source_name": "ETPharma.com", "published_at": "2026-07-14T10:09:50+00:00", "published_display": "14 Jul 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource Falls 3% on Formycon Manufacturing Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxON1dFLXFJRUFPRjJnWWZiVXJ6djJtTnp0TllQVENCRnJ6eHE2cERfOWZma3BaZXdHYWNtYzUydXpZemlMUE54ZGU5Vy0xcW8wYWczNjJKZDVDMExVMlFmc1NQb0dqRmZpX2wtUy1VdXRZTFphX2RiM0RMbnl4Qm1DT1UyRTc?oc=5", "source_name": "Equitypandit", "published_at": "2026-07-14T09:01:29+00:00", "published_display": "14 Jul 2026 09:01", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource Specialty Pharma partners with Formycon AG to manufacture biosimilars", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-07-14T08:33:28+00:00", "published_display": "14 Jul 2026 08:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource Specialty Pharma Partners With Germany's Formycon for Biosimilars Manufacturing", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxObVdpSmN0cXNHUlVKbDF6UkhzTmNhckYwRWxPV0twTHFRWVNxTXVVV0tRM2lxLTVULTNNZm1keTQyR0xnbXV0LTRreTNNWFVwRzFZZEdRRkZWX21xbWExQloxWTRRUG0wVEx0Y3lxbVVzTFN1OFRxM09CZ0h2TS1uS1NUSGFONzRiWUhvZUVhamVxd1JoT2FVdzN4bWVOWHJrZ080SUlHckRpelhlbGpJWVJn?oc=5", "source_name": "Trade Brains", "published_at": "2026-07-14T07:27:00+00:00", "published_display": "14 Jul 2026 07:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource Specialty Pharma ties up with Germany\u2019s Formycon for Biosimilar manufacturing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxQZWlpci1uVVhjYXB1eXZrOGpwMUpSM05RMnhNZTZUbUt6Zjg1VHdoTlhfNFRMZFRyREhlb3JvLXNjOTI5c0NQOFR1akp4SHNzRnJhajVlMmNuRl9yTWFQbjJOTlREQUhFLVFjT0wyZzh6Z2p1UzRJLVVrNEIzQ2VxUTdsVkFfWXQwV1hZcXp1UXowNENkemgwQUJBNWZxLWlaRFA2c1F0WWlBakVXYzdDM2EzbVBZNzdnclVPVFlQVk5KdHBGU2xzdENkSzZJSHBqbGhWai1JM1Y2blVRXzVMNTZxaHROMUxybUpqbTBuanZkYkRJNGhteNIB_wFBVV95cUxOT2p1ZS1OaU9SOGhxdWNVZlV0aXhKcjBMckNaWTZ2X0FhQzdJbEV1X1E1dldoWUhLQWlHUFpZcGRhVmtzMXR0d1JWdW1FZ29nbXd2SWNCT09pMU9NSGpYOTlrZHE1b3hTNHk3bEdMelNjd3c4cEFtaXNWeFc0RklFY1VSVkNZeUdRZjhOdXJnbnhxZjAzQ1hLVW1tQXQwd0toSnNpUmdLdHZ1SDFSTGVKYW9BeHkyVjEtTDI0T0ZYTFJOMTRsRVVrMFZ5OGxHeUlmdHdpVmVBWU5acjJnNFlFdVM0TE13U25YOUZBM1F2bm1pdFlGRUdjcnVQZzJYbkE?oc=5", "source_name": "BusinessLine", "published_at": "2026-07-14T06:48:59+00:00", "published_display": "14 Jul 2026 06:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ONESOURCE Specialty Pharma Signs Strategic Manufacturing Deal With Formycon AG For 5 Global Biosimilars", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNaEkyYU8xdWU5WFZYUEpCYzF2X3FsaFF6MW5SVThzOHFwRGZHWktqNlFnMDdzVFBTUjRnNzVfeUFkczc5UUc1czlyakp6eEt0YjFaM2hoSk90ajZRZVBuSG9fdFBHRTlmM1ptYklBbHFaUFlqLXhoeFA0cW9mVS0xdm9keGwyUDUteXV1RWNYem1lS0k0N3hqTTIzblVPaTQ0dDhwUEozNUZrUW1CQ1gtMC1aYXBBYTBfTUp6M0QzNWdqV09hY251ekVZMWNsX0ZEc1RIVk5LeW9BZw?oc=5", "source_name": "Sahi", "published_at": "2026-07-14T06:46:50+00:00", "published_display": "14 Jul 2026 06:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda\u00ae (Pembrolizumab), in US and Canada", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogJBVV95cUxNSjZUVkJLTWJ2eVY1Sm0xWlRrWWRyd2tOWUNMX2pYVXYzQnE2NUNJZVVoQmlDMGdSLVgxaEh6bTl5WkhNMzVEVG1jME9CMGM4TUE1R1o1aU1IMkhzdU9BMEpORU0wT2piUjF1Q295a2VrZ29hWjkycGZpakwzc1lQTTFWUnRsLU1reFNYUjVRalZITEJYVzM2akh4dlJLUllEZjRUWEZLX3JEX29MWjJ5WFZGM0NUbC1WSlktbVN3SmZOZWVCSktKcjBWR3FhbGJvVmRWZ1hfSGlFRDU5SHRuV0diZzlfN2RZWGlQS2p4dUY4WDdPWVNNT0ZOdG1GUmxSQ0pmN21RT1Y0bVU4TGktODEzeE5IY3hyNW1BNXZVbTI1UQ?oc=5", "source_name": "PR Newswire", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zydus to enter US biosimilar market via Keytruda partnership with Germany's Formycon", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zydus and Formycon ink licensing agreement for biosimilar in US, Canada", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda\u00ae biosimilar candidate FYB206 for the MENA Region", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgJBVV95cUxNVm9PYzJWYzdROXNZcENBLTNPMy1QUFZmQmoxQ05LbjREbm5LdFBCczhWYS1vdVExU3pmV0JJNC1NZlVMRkEtY2ItRlh3WEhQaGk4X1hYaW9XNUZnNTdHMjRyZm1sWEQ2c0pMRjZWYTVzWmtveW5KRWFmRWxDcUJmRGMyd0gwUnZ1Nm8xXzdYSEhGVkJ2Z2d2MlF4dkd5U1loRkpyclk3M2dqOGJxVVpaNmVDeTV1dTViYkNPZWk0c1dIYU1ka1U1Zmx0bGl3UExWeTVxRTAxbXRURHNkLUM3aEluYWYwanJUa1Qza2xWMEdhUUpFQkRWR2RZLTNQbWFmeFJNZXF0bTFrYnk4WE9hYXFn?oc=5", "source_name": "PR Newswire", "published_at": "2025-12-04T08:00:00+00:00", "published_display": "04 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Settlement ends Formycon and Johnson & Johnson FYB202 biosimilar dispute", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPX0YxdVZLMUJvRHZHOVNGbmR3T1Vja01TcXF2eGNISjctbXNub1lobmw4bW9LaHdudVcxZHVnaklkeXllMTBvSkpKS3NpLThGakI5LVZ2NVZfNTJvU2Z6Nno3aUl4VUNtSkF3S05VUkpScWxQM0x3VG5uU3NyZFBsVnR1SjNFcWR4TEZKakNzazRoRlFMN0k2aXV0Sks4T3BqN25pZnk3UnM?oc=5", "source_name": "JUVE Patent", "published_at": "2024-04-05T07:00:00+00:00", "published_display": "05 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon Ag Stock Price Forecast. Should You Buy FYB.DE?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTFBsTFVhclBlbGtVQ1c5ZzVad09JakxsYlRXY0tMemtfNHJ2cm9QdURlRnBLMW94bkNOdGwxWFIydkRPcUJ1TGdkR0JDVQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-22T15:47:40+00:00", "published_display": "22 Dec 2020 15:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon AG: Target Price Consensus and Analysts Recommendations | FYB | DE000A1EWVY8", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE45eE53VFF0OVgxZFc2Tk9LVm02cEVxUHhrdWhUek9sb0Z0dUhDc3NoeHJvRV9LeDI2YVpxZHhVZVVaZnE2MTRSazFNUFFMQW9NcmdSaGE3elMyUnU5U083UnpKMkx0MFd6elJKbGVwNVBvOUNlZlZkQzV3dTFyQQ?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-19T17:22:50+00:00", "published_display": "19 Aug 2020 17:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Formycon AG and OneSource Specialty Pharma Announce Strategic Manufacturing Partnership for Biosimilars", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUWtWY01uYlpzM3JVcHpsamVhZUhrQ3RiY3dhRTNrZTZkV3YtcE5mS0ozODFYVUxSWlBLNTlRcWdYMmJRWjJkVGx6NWJmZktSa0U2M3N1bmo2NjdUcUctWDJMRDdIYTVlajRHT2h1NXRyNnBlODd3dzRyUVNOTVNjSDhnUDdqcEptMHRTU3A1c1BOcWstbHo5YWNSTWJZZHFh?oc=5", "source_name": "Market source", "published_at": "2026-07-14T20:38:34+00:00", "published_display": "14 Jul 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource bags biosimilar manufacturing contract from Formycon", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "ETPharma.com", "published_at": "2026-07-14T10:09:50+00:00", "published_display": "14 Jul 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource Falls 3% on Formycon Manufacturing Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxON1dFLXFJRUFPRjJnWWZiVXJ6djJtTnp0TllQVENCRnJ6eHE2cERfOWZma3BaZXdHYWNtYzUydXpZemlMUE54ZGU5Vy0xcW8wYWczNjJKZDVDMExVMlFmc1NQb0dqRmZpX2wtUy1VdXRZTFphX2RiM0RMbnl4Qm1DT1UyRTc?oc=5", "source_name": "Equitypandit", "published_at": "2026-07-14T09:01:29+00:00", "published_display": "14 Jul 2026 09:01", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource Specialty Pharma partners with Formycon AG to manufacture biosimilars", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-07-14T08:33:28+00:00", "published_display": "14 Jul 2026 08:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource Specialty Pharma Partners With Germany's Formycon for Biosimilars Manufacturing", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxObVdpSmN0cXNHUlVKbDF6UkhzTmNhckYwRWxPV0twTHFRWVNxTXVVV0tRM2lxLTVULTNNZm1keTQyR0xnbXV0LTRreTNNWFVwRzFZZEdRRkZWX21xbWExQloxWTRRUG0wVEx0Y3lxbVVzTFN1OFRxM09CZ0h2TS1uS1NUSGFONzRiWUhvZUVhamVxd1JoT2FVdzN4bWVOWHJrZ080SUlHckRpelhlbGpJWVJn?oc=5", "source_name": "Trade Brains", "published_at": "2026-07-14T07:27:00+00:00", "published_display": "14 Jul 2026 07:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OneSource Specialty Pharma ties up with Germany\u2019s Formycon for Biosimilar manufacturing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxQZWlpci1uVVhjYXB1eXZrOGpwMUpSM05RMnhNZTZUbUt6Zjg1VHdoTlhfNFRMZFRyREhlb3JvLXNjOTI5c0NQOFR1akp4SHNzRnJhajVlMmNuRl9yTWFQbjJOTlREQUhFLVFjT0wyZzh6Z2p1UzRJLVVrNEIzQ2VxUTdsVkFfWXQwV1hZcXp1UXowNENkemgwQUJBNWZxLWlaRFA2c1F0WWlBakVXYzdDM2EzbVBZNzdnclVPVFlQVk5KdHBGU2xzdENkSzZJSHBqbGhWai1JM1Y2blVRXzVMNTZxaHROMUxybUpqbTBuanZkYkRJNGhteNIB_wFBVV95cUxOT2p1ZS1OaU9SOGhxdWNVZlV0aXhKcjBMckNaWTZ2X0FhQzdJbEV1X1E1dldoWUhLQWlHUFpZcGRhVmtzMXR0d1JWdW1FZ29nbXd2SWNCT09pMU9NSGpYOTlrZHE1b3hTNHk3bEdMelNjd3c4cEFtaXNWeFc0RklFY1VSVkNZeUdRZjhOdXJnbnhxZjAzQ1hLVW1tQXQwd0toSnNpUmdLdHZ1SDFSTGVKYW9BeHkyVjEtTDI0T0ZYTFJOMTRsRVVrMFZ5OGxHeUlmdHdpVmVBWU5acjJnNFlFdVM0TE13U25YOUZBM1F2bm1pdFlGRUdjcnVQZzJYbkE?oc=5", "source_name": "BusinessLine", "published_at": "2026-07-14T06:48:59+00:00", "published_display": "14 Jul 2026 06:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ONESOURCE Specialty Pharma Signs Strategic Manufacturing Deal With Formycon AG For 5 Global Biosimilars", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxNaEkyYU8xdWU5WFZYUEpCYzF2X3FsaFF6MW5SVThzOHFwRGZHWktqNlFnMDdzVFBTUjRnNzVfeUFkczc5UUc1czlyakp6eEt0YjFaM2hoSk90ajZRZVBuSG9fdFBHRTlmM1ptYklBbHFaUFlqLXhoeFA0cW9mVS0xdm9keGwyUDUteXV1RWNYem1lS0k0N3hqTTIzblVPaTQ0dDhwUEozNUZrUW1CQ1gtMC1aYXBBYTBfTUp6M0QzNWdqV09hY251ekVZMWNsX0ZEc1RIVk5LeW9BZw?oc=5", "source_name": "Sahi", "published_at": "2026-07-14T06:46:50+00:00", "published_display": "14 Jul 2026 06:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda\u00ae (Pembrolizumab), in US and Canada", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogJBVV95cUxNSjZUVkJLTWJ2eVY1Sm0xWlRrWWRyd2tOWUNMX2pYVXYzQnE2NUNJZVVoQmlDMGdSLVgxaEh6bTl5WkhNMzVEVG1jME9CMGM4TUE1R1o1aU1IMkhzdU9BMEpORU0wT2piUjF1Q295a2VrZ29hWjkycGZpakwzc1lQTTFWUnRsLU1reFNYUjVRalZITEJYVzM2akh4dlJLUllEZjRUWEZLX3JEX29MWjJ5WFZGM0NUbC1WSlktbVN3SmZOZWVCSktKcjBWR3FhbGJvVmRWZ1hfSGlFRDU5SHRuV0diZzlfN2RZWGlQS2p4dUY4WDdPWVNNT0ZOdG1GUmxSQ0pmN21RT1Y0bVU4TGktODEzeE5IY3hyNW1BNXZVbTI1UQ?oc=5", "source_name": "PR Newswire", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zydus to enter US biosimilar market via Keytruda partnership with Germany's Formycon", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zydus and Formycon ink licensing agreement for biosimilar in US, Canada", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda\u00ae biosimilar candidate FYB206 for the MENA Region", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgJBVV95cUxNVm9PYzJWYzdROXNZcENBLTNPMy1QUFZmQmoxQ05LbjREbm5LdFBCczhWYS1vdVExU3pmV0JJNC1NZlVMRkEtY2ItRlh3WEhQaGk4X1hYaW9XNUZnNTdHMjRyZm1sWEQ2c0pMRjZWYTVzWmtveW5KRWFmRWxDcUJmRGMyd0gwUnZ1Nm8xXzdYSEhGVkJ2Z2d2MlF4dkd5U1loRkpyclk3M2dqOGJxVVpaNmVDeTV1dTViYkNPZWk0c1dIYU1ka1U1Zmx0bGl3UExWeTVxRTAxbXRURHNkLUM3aEluYWYwanJUa1Qza2xWMEdhUUpFQkRWR2RZLTNQbWFmeFJNZXF0bTFrYnk4WE9hYXFn?oc=5", "source_name": "PR Newswire", "published_at": "2025-12-04T08:00:00+00:00", "published_display": "04 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Settlement ends Formycon and Johnson & Johnson FYB202 biosimilar dispute", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPX0YxdVZLMUJvRHZHOVNGbmR3T1Vja01TcXF2eGNISjctbXNub1lobmw4bW9LaHdudVcxZHVnaklkeXllMTBvSkpKS3NpLThGakI5LVZ2NVZfNTJvU2Z6Nno3aUl4VUNtSkF3S05VUkpScWxQM0x3VG5uU3NyZFBsVnR1SjNFcWR4TEZKakNzazRoRlFMN0k2aXV0Sks4T3BqN25pZnk3UnM?oc=5", "source_name": "JUVE Patent", "published_at": "2024-04-05T07:00:00+00:00", "published_display": "05 Apr 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon Ag Stock Price Forecast. Should You Buy FYB.DE?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiS0FVX3lxTFBsTFVhclBlbGtVQ1c5ZzVad09JakxsYlRXY0tMemtfNHJ2cm9QdURlRnBLMW94bkNOdGwxWFIydkRPcUJ1TGdkR0JDVQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-22T15:47:40+00:00", "published_display": "22 Dec 2020 15:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Formycon AG: Target Price Consensus and Analysts Recommendations | FYB | DE000A1EWVY8", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE45eE53VFF0OVgxZFc2Tk9LVm02cEVxUHhrdWhUek9sb0Z0dUhDc3NoeHJvRV9LeDI2YVpxZHhVZVVaZnE2MTRSazFNUFFMQW9NcmdSaGE3elMyUnU5U083UnpKMkx0MFd6elJKbGVwNVBvOUNlZlZkQzV3dTFyQQ?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-19T17:22:50+00:00", "published_display": "19 Aug 2020 17:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 71, "total_relevant": 14, "sentiment_summary": {"positive": 1, "negative": 1, "neutral": 12, "score": 49, "total": 14, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 77, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 4.2, "count": 7}, {"event": "general", "label": "Market update", "weight": 3.45, "count": 5}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 18.8, "latest_week": "2026-07-10", "one_week_move": -1.7, "four_week_move": -8.5, "twelve_week_move": -5.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.26712, "market_dynamics_buy_signal": false, "relative_strength": -18.459992, "fair_value_gap": -51.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.4268, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.7% over one week, -8.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 2}, {"label": "Market source", "count": 1}, {"label": "ETPharma.com", "count": 1}, {"label": "Equitypandit", "count": 1}, {"label": "The Economic Times", "count": 1}, {"label": "Trade Brains", "count": 1}, {"label": "BusinessLine", "count": 1}, {"label": "Sahi", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 14}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 7}, {"label": "Market update", "count": 5}, {"label": "Guidance", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "14", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.7% over one week, -8.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Formycon AG and OneSource Specialty Pharma Announce Strategic Manufacturing Partnership for Biosimilars"}], "updated_at": "2026-07-17T05:00:21.543393+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}